Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism

European Journal of Neuroscience

Volumn 28, Issue 3, 2008, Pages 610-617

  Anderson, D W ^a   Bradbury, K A ^a   Schneider, J S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Dopamine; Parkinsonism; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DNA; DOPAMINE; NICOTINAMIDE; NICOTINIC ACID; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE; VITAMIN B COMPLEX;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL LOSS; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN DEPLETION; STRIATE CORTEX; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; NIACINAMIDE; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; TYROSINE 3-MONOOXYGENASE; VITAMIN B COMPLEX;

EID: 47849083267     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2008.06356.x     Document Type: Article

References (31)

1. Anderson, D.W., Neavin, T., Smith, J.A. Schneider, J.S. (2001) Neuroprotective effects of pramipexole in young and aged MPTP-treated mice. Brain Res., 905, 44 53.
2. Anderson, D.W., Bradbury, K.A. Schneider, J.S. (2006) Neuroprotection in Parkinson models varies with toxin administration protocol. Eur. J. Neurosci., 24, 3174 3182.
3. Anglade, P., Vyas, S., Hirsch, E.C. Agid, Y. (1997a) Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol. Histopathol., 12, 603 610.
4. Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M.T., Michel, P.P., Marquez, J., Mouatt-Prigent, A., Ruberg, M., Hirsch, E.C. Agid, Y. (1997b) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol., 12, 25 31.
5. Ayoub, I.A., Lee, E.J., Ogilvy, C.S., Beal, M.F. Maynard, K.I. (1999) Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats. Neurosci. Lett., 259, 21 24.
6. Banati, R.B., Daniel, S.E. Blunt, S.B. (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord., 13, 221 227.
7. Beal, M.F. (2003) Bioenergetic approaches for neuroprotection in Parkinson's disease. Ann. Neurol., 53 (Suppl. 3 S39 S47 discussion S47 S38.
8. Cosi, C., Colpaert, F., Koek, W., Degryse, A. Marien, M. (1996) Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res., 729, 264 269.
9. Franklin, K.B.J. Paxinos, G. 1992. The Mouse Brain in Stereotaxic Coordinates. Academic Press, London.
10. Furuya, T., Hayakawa, H., Yamada, M., Yoshimi, K., Hisahara, S., Miura, M., Mizuno, Y. Mochizuki, H. (2004) Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of parkinson's disease. J. Neurosci., 24, 1865 1872.
11. Hartley, A., Stone, J.M., Heron, C., Cooper, J.M. Schapira, A.H. (1994) Complex I Inhibitors induce dose-dependant apoptosis in PC12 cells: relevance to Parkinson's disease. J. Neurochem., 63, 1987 1990.
12. Hoane, M.R., Gilbert, D.R., Holland, M.A. Pierce, J.L. (2006a) Nicotinamide reduces acute cortical neuronal death and edema in the traumatically injured brain. Neurosci. Lett., 408, 35 39.
13. Hoane, M.R., Kaplan, S.A. Ellis, A.L. (2006b) The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury. Brain Res., 1125, 185 193.
14. Hoane, M.R., Tan, A.A., Pierce, J.L., Anderson, G.D. Smith, D.C. (2006c) Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat. J. Neurotrauma, 23, 1535 1548.
15. Jackson-Lewis, V., Jakowec, M., Burke, R.E. Przedborski, S. (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration, 4, 257 269.
16. Jellinger, K.A. (2000) Cell death mechanisms in Parkinson's disease. J. Neural Transm., 107, 1 29.
17. Jenner, P. (2003) Oxidative stress in Parkinson's disease. Ann. Neurol., 53 (Suppl. 3 S26 S36 discussion S36 S28.
18. Kaufmann, W.K. Kaufman, D.G. (1993) Cell cycle control, DNA repair and initiation of carcinogenesis. FASEB J., 7, 1188 1191.
19. Kingsbury, A.E., Mardsen, C.D. Foster, O.J. (1998) DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov. Disord., 13, 877 884.
20. Klaidman, L.K., Mukherjee, S.K. Adams, J.D. (2001) Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim. Biophys. Acta (BBA) - General Subjects, 1525, 136 148.
21. Kosel, S., Egensperger, R., von Eitzen, U., Mehraein, P. Graeber, M.B. (1997) On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol. (Berl)., 93, 105 108.
22. Maiese, K. Chong, Z.Z. (2003) Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol. Sci., 24, 228 232.
23. Mandir, A.S., Przedborski, S., Jackson-Lewis, V., Wang, Z.-Q., Simbulan-Rosenthal, C.M., Smulson, M.E., Hoffman, B.E., Guastella, D.B., Dawson, V.L. Dawson, T.M. (1999) Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc. Natl Acad. Sci. USA, 96, 5774 5779.
24. Mochizuki, H., Goto, K., Mori, H. Mizuno, Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci., 137, 120 123.
25. Mukherjee, S.K., Klaidman, L.K., Yasharel, R. Adams, J.D. Jr (1997) Increased brain NAD prevents neuronal apoptosis in vivo. Eur. J. Pharmacol., 330, 27 34.
26. Przedborski, S. Vila, M. (2003) The 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Ann. N. Y. Acad. Sci., 991, 189 198.
27. Tatton, N.A. (2000) Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol., 166, 29 43.
28. Tatton, N.A. Kish, S.J. (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience, 77, 1037 1048.
29. Tatton, N.A., Maclean-Fraser, A., Tatton, W.G., Perl, D.P. Olanow, C.W. (1998) A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann. Neurol., 44, S142 S148.
30. Virag, L. Whittington, R.A. (2002) Highly sensitive chromatographic assay for dopamine determination during in vivo cerebral microdialysis in the rat. J. Chromatogr., 772, 267 272.
31. Yang, J., Klaidman, L.K., Chang, M.L., Kem, S., Sugawara, T., Chan, P. Adams, J.D. (2002) Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model. Pharmacol. Biochem. Behav., 73, 901 910.